Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 42
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Bukh, J. D. Andersen, P. K. and Kessing, L. V. 2016. Rates and predictors of remission, recurrence and conversion to bipolar disorder after the first lifetime episode of depression – a prospective 5-year follow-up study. Psychological Medicine, Vol. 46, Issue. 06, p. 1151.

    MacKinnon, Dean F. 2015. Psychiatry.

    Mowla, Arash Ahmadzadeh, Laaya Razeghian Jahromi, Leila and Dastgheib, Seyed Ali 2015. Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized Clinical Trial. Clinical Drug Investigation, Vol. 35, Issue. 8, p. 513.

    Prina, A. Matthew Cosco, Theodore D. Dening, Tom Beekman, Aartjan Brayne, Carol and Huisman, Martijn 2015. The association between depressive symptoms in the community, non-psychiatric hospital admission and hospital outcomes: A systematic review. Journal of Psychosomatic Research, Vol. 78, Issue. 1, p. 25.

    Almeida, Osvaldo P Marsh, Kylie Flicker, Leon Hickey, Martha Ford, Andrew and Sim, Moira 2014. Reducing depression during the menopausal transition: study protocol for a randomised controlled trial. Trials, Vol. 15, Issue. 1,

    Bulloch, Andrew Williams, Jeanne Lavorato, Dina and Patten, Scott 2014. RECURRENCE OF MAJOR DEPRESSIVE EPISODES IS STRONGLY DEPENDENT ON THE NUMBER OF PREVIOUS EPISODES. Depression and Anxiety, Vol. 31, Issue. 1, p. 72.

    Gerrits, Marloes MJG van Oppen, Patricia Leone, Stephanie S van Marwijk, Harm WJ van der Horst, Henriëtte E and Penninx, Brenda W 2014. Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders. BMC Psychiatry, Vol. 14, Issue. 1,

    Gorwood, P. Richard-Devantoy, S. Baylé, F. and Cléry-Melun, M.L. 2014. Psychomotor retardation is a scar of past depressive episodes, revealed by simple cognitive tests. European Neuropsychopharmacology, Vol. 24, Issue. 10, p. 1630.

    Leckband, Susan G. 2014. Pharmacogenomic testing for treatment resistant depression. Mental Health Clinician, Vol. 4, Issue. 5, p. 236.

    Hardeveld, Florian Spijker, Jan De Graaf, Ron Hendriks, Sanne M. Licht, Carmilla M.M. Nolen, Willem A. Penninx, Brenda W.J.H. and Beekman, Aartjan T.F. 2013. Recurrence of major depressive disorder across different treatment settings: Results from the NESDA study. Journal of Affective Disorders, Vol. 147, Issue. 1-3, p. 225.

    Mechakra-Tahiri, Djemaa-Samia Zunzunegui, Maria Victoria Berbiche, Djamal and Brassard, Joëlle 2013. Pattern of Change of Depressive Disorder over a One-Year Period among Community-Dwelling Older Adults in Québec. Depression Research and Treatment, Vol. 2013, p. 1.

    Hudson, Christopher G. 2012. Declines in mental illness over the adult years: An enduring finding or methodological artifact?. Aging & Mental Health, Vol. 16, Issue. 6, p. 735.

    Shimodera, Shinji Furukawa, Toshi A Mino, Yoshio Shimazu, Kae Nishida, Atsushi and Inoue, Shimpei 2012. Cost-effectiveness of family psychoeducation to prevent relapse in major depression: Results from a randomized controlled trial. BMC Psychiatry, Vol. 12, Issue. 1,

    Katsuki, Fujika Takeuchi, Hiroshi Konishi, Mizuho Sasaki, Megumi Murase, Yuka Naito, Atsuko Toyoda, Hiroko Suzuki, Masako Shiraishi, Nao Kubota, Yosuke Yoshimatsu, Yoshiko and Furukawa, Toshiaki A 2011. Pre-post changes in psychosocial functioning among relatives of patients with depressive disorders after Brief Multifamily Psychoeducation: A pilot study. BMC Psychiatry, Vol. 11, Issue. 1,

    Perry, Deborah F Nicholson, Wanda Christensen, Anna L and Riley, Anne W 2011. A Public Health Approach to Addressing Perinatal Depression. International Journal of Mental Health Promotion, Vol. 13, Issue. 3, p. 5.

    Richards, Derek 2011. Prevalence and clinical course of depression: A review. Clinical Psychology Review, Vol. 31, Issue. 7, p. 1117.

    Roca, Miquel García-Toro, Mauro García-Campayo, Javier Vives, Margalida Armengol, Silvia García-García, Margarita Asensio, David and Gili, Margalida 2011. Clinical differences between early and late remission in depressive patients. Journal of Affective Disorders, Vol. 134, Issue. 1-3, p. 235.

    Shimazu, K. Shimodera, S. Mino, Y. Nishida, A. Kamimura, N. Sawada, K. Fujita, H. Furukawa, T. A. and Inoue, S. 2011. Family psychoeducation for major depression: randomised controlled trial. The British Journal of Psychiatry, Vol. 198, Issue. 5, p. 385.

    Farabaugh, Amy H. Bitran, Stella Witte, Janet Alpert, Jonathan Chuzi, Sarah Clain, Alisabet J. Baer, Lee Fava, Maurizio McGrath, Patrick J. Dording, Christina Mischoulon, David and Papakostas, George I. 2010. Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome. International Clinical Psychopharmacology, Vol. 25, Issue. 4, p. 214.

    Nierenberg, A. A. Husain, M. M. Trivedi, M. H. Fava, M. Warden, D. Wisniewski, S. R. Miyahara, S. and Rush, A. J. 2010. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychological Medicine, Vol. 40, Issue. 01, p. 41.


Time to recurrence after recovery from major depressive episodes and its predictors

  • T. KANAI (a1), H. TAKEUCHI (a1), T. A. FURUKAWA (a1), R. YOSHIMURA (a1), T. IMAIZUMI (a1), T. KITAMURA (a1) and K. TAKAHASHI (a1)
  • DOI:
  • Published online: 01 July 2003

Background. Depression is a remitting but recurring disease. However, there is a paucity of prospectively recorded data on the course of depression after recovery.

Method. A multi-centre prospective serial follow-up study of an inception cohort of hitherto untreated unipolar major depression (N=95) for 6 years. We report the time to recurrence after recovery from the index depressive episode and their predictors.

Results. The cumulative probability of remaining well without subthreshold symptoms was 57% (95% CI, 46 to 68%) at 1 year, 47% (95% CI, 36 to 58%) at 2 years and 35% (95% CI, 23 to 47%) at 5 years. The same without full relapse was 79% (95% CI, 70 to 88%) at 1 year, 70% (95% CI, 60 to 80%) at 2 years and 58% (95% CI, 46 to 70%) at 5 years. The median duration of well-interval from the end of the index episode to the beginning of the subthreshold episode was 19·0 months (95% CI, 2·4 to 35·7), and that to the end of the full episode was over 6 years. Residual symptoms at time of recovery predicted earlier recurrence.

Conclusions. The median length of the well-interval was much longer than previously reported in studies employing similar definitions but dealing with a more severe spectrum of patients. However, the sobering fact remains that less than half of the patients can expect to remain virtually symptom-free for 2 years or more after recovery from the depressive episode.

Corresponding author
Professor Toshi A. Furukawa, Department of Psychiatry, Nagoya City University Medical School, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *